Next Article in Journal
Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma
Previous Article in Journal
Oral Lipid Nanoparticles for Improving the Efficiency of Drug Delivery Systems in Ulcerative Colitis: Recent Advances and Future Prospects
Previous Article in Special Issue
The Role of Photodynamic Therapy Mediated by Natural Photosensitisers in the Management of Peri-Implantitis: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Natural Anthraquinone Parietin Inactivates Candida tropicalis Biofilm by Photodynamic Mechanisms

by
Juliana Marioni
1,2,
Bianca C. Romero
1,3,
Ma. Laura Mugas
1,4,
Florencia Martinez
5,6,
Tomas I. Gómez
1,3,5,
Jesús M. N. Morales
2,
Brenda S. Konigheim
5,6,
Claudio D. Borsarelli
2 and
Susana C. Nuñez-Montoya
1,3,*
1
Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba X5000HUA, Argentina
2
Instituto de Bionanotecnología del NOA (INBIONATEC), Universidad Nacional de Santiago del Estero—CONICET, RN9, Km 1125, Santiago del Estero G4206XCP, Argentina
3
CONICET, Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba X5000HUA, Argentina
4
Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET and Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Córdoba 2351 1er subsuelo, Ciudad de Buenos Aires 1120AAF, Argentina
5
Instituto de Virología “Dr. J. M. Vanella”, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba X5000HUA, Argentina
6
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba X5000HUA, Argentina
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(5), 548; https://doi.org/10.3390/pharmaceutics17050548
Submission received: 14 March 2025 / Revised: 11 April 2025 / Accepted: 11 April 2025 / Published: 23 April 2025
(This article belongs to the Special Issue Natural Products in Photodynamic Therapy)

Abstract

:
Background/Objectives: Parietin (PTN), a blue-light absorbing pigment from Teloschistes spp. lichens, exhibit photosensitizing properties via Type I (superoxide anion, O2•−) and Type II (singlet oxygen, 1O2) mechanisms, inactivating bacteria in vitro after photoexcitation. We evaluate the in vitro antifungal activity of PTN against Candida tropicalis biofilms under actinic irradiation, its role in O2•− and 1O2 production, and the cellular stress response. Methods: Minimum inhibitory concentration (MIC) of PTN was determined in C. tropicalis NCPF 3111 under dark and actinic light conditions. Biofilm susceptibility was assessed at MIC/2, MIC, MICx2, MICx4, and MICx6 in the same conditions, and viability was measured by colony-forming units. Photodynamic mechanisms were examined using Tiron (O2•− scavenger) or sodium azide (1O2 quencher). O2•− production was measured by the nitro-blue tetrazolium (NBT) reduction and nitric oxide (NO) generation by Griess assay. Total antioxidant capacity was studied by FRAP (Ferrous Reduction Antioxidant Potency) assay and superoxide dismutase (SOD) activity by NBT assay. Results: Photoexcitation of PTN reduced C. tropicalis biofilm viability by four logs at MICx2. Sodium azide partially reversed the effect, whereas Tiron fully inhibited it, indicating the critical role of O2•−. PTN also increased O2•− and NO levels, enhancing SOD activity and FRAP. However, this antioxidant response was insufficient to prevent biofilm photoinactivation. Conclusions: Photoinactivation of C. tropicalis biofilms by PTN is primarily mediated by O2•−, with a minor contribution from 1O2 and an imbalance in NO levels. These findings suggest PTN is a promising photosensitizer for antifungal photodynamic therapy.

Graphical Abstract

1. Introduction

Antimicrobial (ATM) resistance is currently a global problem that hinders the treatment of common infections, increasing the risk of serious and even fatal complications. The prolonged duration of treatment has ramifications for other domains, including the escalation of healthcare costs, both for patients and healthcare systems, due to the use of more complex and expensive treatments. Furthermore, ATM resistance reduces the safety of some medical procedures (surgeries, transplants, cancer treatments) by increasing the risk of resistant infections. This is compounded by the rapid spread of infection, which makes it difficult to control and increases the risk of epidemic outbreaks [1].
Invasive fungal infections represent a significant challenge in the clinical setting, especially those caused by species of the genus Candida, an opportunistic fungus responsible for most hospital-acquired infections with a high morbidity and mortality rate. The ability of Candida spp. to exhibit ATM resistance has been linked to their capacity to form biofilms, which are distinct in that they are formed by both morphotypes—the yeast and hyphal forms—that intertwine to create a complex three-dimensional structure. This structure affords biofilms greater resistance to traditional antifungals than their planktonic counterparts. Within this group, Candida tropicalis stands out for its ability to form biofilms that are highly resistant to conventional treatments, which makes eradication difficult and favors the persistence of infections in immunocompromised patients [2,3].
In the face of ATM resistance, a multitude of strategies have been proposed. Among these, antimicrobial photodynamic inactivation (aPDI) has emerged as a promising approach. This strategy involves the generation of reactive oxygen species (ROS) following the excitation of a photosensitizer (PS) with light of a specific wavelength. This approach has proven to be effective against various pathogenic bacteria, parasites, viruses, and fungi, controlling toxicity on human cells by matching the three necessary factors (PS at a non-active concentration in darkness, light, and oxygen) in the area to be treated. The triplet excited state of the PS (3PS*) may react with molecular oxygen (3O2) by two mechanisms: a charge transfer reaction to generate superoxide anion radical (O2•−), or an energy transfer reaction generating singlet molecular oxygen (1O2), also called Type I and Type II processes, respectively. These species thus generated and the species derived from them by secondary reactions (hydrogen peroxide: H2O2; and hydroxyl radical: HO), are ultimately those that oxidize the biological molecules in their direct environment (proteins, lipids, DNA), triggering cellular oxidative stress that eventually leads to the death of the microorganisms, which translates into regression of the infection [4,5].
In the search for new therapeutic agents, natural products have become of interest due to their structural diversity and bioactive potential [6]. Among them, lichens are an important source of secondary metabolites with antimicrobial, antioxidant, and cytotoxic properties [7,8,9,10,11,12]. These symbiotic associations between fungi and algae or cyanobacteria produce a wide variety of terpenoid and phenolic derivatives, including among the latter anthraquinones (AQs), many of which have demonstrated activity against pathogenic bacteria and fungi [7].
AQs are a family of compounds found in higher plants and lichens with photoactive properties and potential antimicrobial activity. Some AQ derivatives have shown the ability to generate ROS under irradiation, suggesting their possible application in the inactivation of pathogens. However, the mechanism of action of these molecules and their impact on the viability and structure of fungal biofilms still require further investigation [13,14].
Parietin (PTN), 1,8-dihydroxy-3-methoxy-6-methyl-9,10-anthraquinone (Figure 1), is found as orange crystals in the upper crust of lichens of the Teloschistaceae family, acting as an UV-B photoprotective pigment [15]. However, we have previously shown that PTN diluted in organic solvents such as chloroform is an efficient PS of 1O2 with a high quantum yield (ΦΔ = 0.69) as well as an O2•− photogenerator in aqueous media [16].
In this work, the in vitro antifungal and antibiofilm activity of PTN was evaluated both in dark conditions and under irradiation. The aim is to determine its potential as a PS against C. tropicalis biofilms. The involvement of Type I and Type II photosensitizing mechanisms in the generation of ROS was analyzed; and because of this, the generation of reactive nitrogen intermediates (RNI) was also assessed, since these species can be formed as a secondary process of deactivation of O2•−. The superoxide dismutase enzyme (SOD) activity and the total antioxidant capacity of the biological system (employing FRAP, Ferrous-Reducing Antioxidant Potency assay) were also evaluated, to establish whether oxidative or nitrosative stress would be responsible for the observed biological effect [17,18,19].
The results of this study indicate that the photoinactivation of Candida tropicalis biofilms by PTN is predominantly driven by the O2•− generation (Type I mechanism). Although the 1O2 (Type II mechanism) also plays a role in this process, its contribution is considerably smaller compared to O2•−. Furthermore, the study revealed an imbalance in NO levels, which likely exacerbates the overall cellular stress response, contributing to the effectiveness of the photodynamic treatment. Given these findings, PTN shows strong potential as an effective PS in antifungal photodynamic therapy (aPDT), offering a promising therapeutic approach for treating fungal biofilm-related infections.

2. Materials and Methods

2.1. Reagents and Solvents

Sabouraud dextrose broth (SDB) and Sabouraud dextrose agar (SDA) were obtained from Britania, CABA, Argentina. Sodium nitrite (NaNO2), and ferrous sulfate (FeSO4) were acquired from Cicarelli, Sta. Fe, Argentina. Sodium hydroxide (NaOH, Biopack, Zárate, Argentina) and Amphotericin B (AmB, Richet, Tres Arroyos, Argentina), phosphate-buffered saline (PBS) were also acquired. Roswell Park Memorial Institute 1640 (RPMI), morpholine propane sulfonic acid (MOPS), sodium azide (NaN3), Tiron, nitro-blue tetrazolium (NBT), methionine, and riboflavin were purchased from Sigma, St. Louis, MO, USA. Water and distilled solvents (Sintorgan, Buenos Aires, Argentina) were used.

2.2. Yeast Strain and Growth Conditions

A standard strain was used: Candida tropicalis NCPF 3111 (National Collection of Pathogenic Fungi, Bristol, UK). It was conserved and reactivated according to Clinical and Laboratory Standards Institute guidelines (CLSI, 2002) [20]. Sabouraud dextrose broth (SDB) was used as a growth medium at 37 °C.

2.3. Natural Photosensitizer Tested

Parietin (PTN) (Figure 1) was obtained from the lichen Teloschistes nodulifer (Nyl.) Hillman (Teloschistáceas, identified as CORDC00005354, Museo Botánico de Córdoba, Universidad Nacional Córdoba). In the purification and identification process, the methodology previously developed was followed to obtain a purity of 95%, according to HPLC [21,22]. A hydroalcoholic solution of PTN (3.5 mM) was used as a stock solution, containing 1% ethanol (EtOH). The tested concentrations were prepared by diluting the stock with a culture medium, depending on whether the assay was carried out on planktonic yeasts or biofilm.

2.4. Irradiation System

Photoinactivation assays were carried out using an actinic Phillips 20W lamp (380 ± 480 nm, 0.65 mWcm−2, Madrid, Spain) with an emission maximum at 420 nm, which was placed inside a black box at 20 cm above the samples [22].

2.5. Photoactive Minimum Inhibitory Concentration

The lowest concentration of the compound that inhibits the growth of the planktonic form of C. tropicalis was determined. The protocol described by CLSI (2008) [23] was applied to determine the minimum inhibitory concentration (MIC), adapted to be carried out under dark and irradiated conditions [24]. This allows the establishment of the photoactivated MIC (pMIC) in comparison to the MIC in darkness, suggesting the photodynamic potential of the PS. The assay was carried out on 96-well microplates (Greiner Bio-One, Frickenhausen, Germany) containing the following culture medium: RPMI 1640 with glutamine and 0.2% glucose, without sodium bicarbonate, buffered with 0.164 M MOPS and adjusting the pH to 7 with 1N NaOH. PTN solutions (100 μL) were added to each well following the additive serial double dilution method and twelve concentrations between 0.24 and 500 µg/mL were tested in triplicate. AmB was the positive control (+C), used at its MIC. The yeast suspension (100 μL) was then added to each well with a final concentration of 0.5 × 103–2.5 × 103 CFU/mL. One set of these concentrations was irradiated for 15 min at room temperature, whereas another set was shielded from light. Immediately after this time, both sets were incubated at 37 °C for 48 h. Finally, the optical density (OD) of each well was measured at 490 or 530 nm on a microplate reader (Tecan Sunrise Model, TECAN, Grödig, Austria). RPMI and yeast suspension with 1% EtOH, both without PTN, were embraced as controls (in triplicate) in both experimental conditions.
In addition, a colony-forming unit (CFU) count assay was performed. A sample (100 µL) was taken from each well, which was diluted 1:10 in PBS until final dilution 1:1,000,000. Subsequently, each suspension (100 μL) was seeded on Sabouraud dextrose agar (SDA) plates and incubated for 48 h at 37 °C. Before incubation, the CFU were counted to establish the minimum fungicidal concentration (MFC), defined as the lowest concentration of a compound that kills 99.9% of a fungal inoculum.

2.6. Photoinactivation Biofilm Procedures

Biofilms were formed in flat-bottomed 96-well microplates (Greiner Bio-One, Frickenhausen, Germany), following an adaptation from the method of O’Toole & Kolter [22]. Once a 48 h biofilm formation in SDB was achieved, the microplates were rinsed twice with PBS (200 µL × 2) at pH = 7 to remove non-adherent cells. PTN was tested on C. tropicalis biofilms at five concentrations in triplicate: pMIC/2, pMIC, pMICx2, pMICx4, and pMICx6, under darkness and irradiation conditions. SDB alone and SDB with 1% EtOH were included as negative controls. AmB (+C) was used as a positive control at MIC. After treatment, microplates were incubated at 37 °C for 48 h. The supernatant was replaced by PBS (100 µL per well) and sonicated (40 kHz, 60 s in Codyson CD4831, Shenzhen, China). The biofilm of each well was removed and serially diluted with PBS. Each dilution was plated (10 μL) on the SDA plate in triplicate, and the number of CFUs formed after 48 h incubation at 37 °C was counted. The counting of CFU/mL was log-transformed.

2.7. Mechanism Action Studies

To determine the mechanism of photosensitizing action, the scavenging effect of sodium azide on singlet oxygen (1O2 quencher) or Tiron on superoxide anion (O2•− scavenger) was evaluated in PTN-treated and untreated biofilm, both in the presence and absence of light [25]. Quencher/scavenger and PTN solutions were added on a dense biofilm (48 h) at the same time, so that the final concentration of each was 200 μM and the PTN concentrations were pMIC/2, pMIC, pMICx2, pMICx4, pMICx6. After darkness and irradiation treatment (15 min), the procedure continued as described above for CFU quantification.
Each supernatant of both microplates (dark and light) was extracted to assess the production of O2•−, reactive nitrogen intermediates (RNI), and the activation of the antioxidant system: SOD and total non-enzymatic system using the FRAP assay.
Production of O2•− was determined by the nitro-blue tetrazolium (NBT) reduction method [26]. Blue diformazan formation is proportional to the generated O2•− in biofilms and its OD was measured at 540 nm on the same microplate reader. Results were expressed as OD540nm/CFU (Superoxide anion/CFU.mL−1) [22].
RNI generation was evaluated as nitrite formation, by using the Griess reaction and a calibration curve of NaNO2 as the standard [27]. OD was measured spectrophotometrically at 540 nm [22] and results were expressed as the ratio between nitrite concentration values/CFU (RNI/CFU.mL−1).
SOD activity was evaluated by the ability of this enzyme to inhibit NBT reduction in the presence of O2•−, generated by the photostimulation of riboflavin in the presence of oxygen and an electron donor (methionine). Results were expressed as SOD activation (%SOD/CFU.mL−1) [22,28].
FRAP assay was used following the methodology described by Benzie & Strain (1996) [29]. The absorbance was measured at 593 nm and results were expressed as the Fe2+ concentration values/CFU (FRAP/CFU.mL−1) by using a FeSO4 calibration curve [22].

2.8. Statistical Analysis

All assays were made in triplicate of three independent experiments. Data were expressed as means ± standard deviation. A p-value < 0.05 was considered statistically significant, obtained by the t-Student–Newman–Keuls test for multiple comparisons. The symbol * denotes statistical significance at p < 0.05 when compared to untreated biofilms and # indicates statistical significance at p < 0.05 when darkness and irradiation were compared.

2.9. Declaration of Generative AI–AI-Assisted Technologies

During the preparation of this work, the author(s) used ChatGPT (GPT-4 version) to improve the redaction and grammar of English. After using this tool/service, the authors reviewed and edited the content as needed and assume full responsibility for the publication’s content.

3. Results

3.1. Photoactive Minimum Inhibitory Concentration (pMIC)

PTN produced most significant growth inhibition of planktonic yeasts of C. tropicalis at 0.98 μg/mL (≈3.45 µM) under irradiation conditions, as defined as the photoactive MIC (Figure 2). Furthermore, these values are below the cytotoxic concentration of PTN, since the cell viability of Vero cells was 80% and 60% at 100 µg/mL, under darkness and light, respectively [16]. In contrast, in the dark, PTN only produces 20% growth inhibition; therefore, it is not possible to determine its MIC.

3.2. PTN Antimicrobial Photodynamic Therapy (APDT)

The antifungal activity of PTN was also tested on C. tropicalis biofilms at five concentrations taking as reference the pMIC value (0.98 μg/mL ≈ 3.45 μM), obtained in yeast suspensions. CFU were not affected by light conditions. Regarding the antibiofilm activity of PTN on C. tropicalis (Figure 3), we can state that it had no effect at the tested concentrations in the dark. On the other hand, when PTN was photostimulated, it could be observed that the photodynamic effect was concentration-dependent, starting at the pMIC and the most active concentration being pMICx2 (≈2 μg/mL), as it produced a 4-log CFU reduction. At the highest concentrations tested, no photoinactivation was observed, probably because molecular aggregates of PTN in aqueous media increase the prompt non-radiative deactivation of the singlet excited state, avoiding the generation of the 3PTN* and therefore the photogeneration of ROS [25].

3.2.1. Photodynamic Mechanism on Analysis After PTN-APDT

To clarify the photoinactivation mechanism, the amount of photogenerated ROS was analyzed in the presence of specific ROS scavengers or quenchers. Thus, the quenching effect of 200 mM sodium azide on 1O2 or the scavenging of O2•− by 200 mM Tiron on biofilm photoinactivation by PTN is shown in Figure 3. The addition of Tiron completely inhibited the photodynamic effect of PTN at all bioactive concentrations (pMIC and pMICx2). In contrast, sodium azide exhibited approximately half the efficacy of Tiron. Although it was unable to reverse the action of the O2•−, sodium azide significantly increased the survival of biofilms by almost three logs at these concentrations.

3.2.2. Biofilm Stress Response After PTN-APDT

The O2•− generation and nitrosative metabolite production were studied for the photoinactivation process of PTN on C. tropicalis biofilms. An increment in O2•− levels was observed when PTN was photoexcited at pMIC/2, pMIC, and pMICx2 with respect to untreated biofilms (Figure 4, blue bars). In addition, at the higher PTN concentrations tested, no increase in this ROS was detected. In relation to RNI generation by this AQ when it was photostimulated on biofilms (Figure 4, red bars), the rise in RNI was greater for the most active concentration of PTN than the other concentrations tested.
Furthermore, the stimulation of SOD activity (Figure 5, magenta bars) was observed at the photoactive concentrations of PTN (pMIC and pMICx2). The levels of total antioxidant capacity (FRAP) in the treated biofilm increased at all conditions evaluated compared to the untreated biofilm (Figure 5, green bars). Moreover, both defense systems (SOD and FRAP) were detected even in higher proportion for pMICx2.

4. Discussion

The treatment of candidiasis is a multifaceted process, due to the pathogenic mechanisms of Candida spp., particularly their ability to form biofilms and their acquired resistance or multi-resistance, which represents a significant public health concern [3]. Given this challenge, aPDI is being investigated as a possible alternative for treating fungal infections, which was the motivation for this study [30].
In this study, we started by investigating the effect of PTN-mediated PDI on planktonic yeast of C. tropicalis. The results showed negligible toxicity in samples treated with AQ and darkness (<20% growth inhibition). This is consistent with a previous study that reported PTN induced low cytotoxicity in Vero cells. Furthermore, in this previous work, PTN had antibacterial effect on both Gram-positive and -negative strains only after photostimulation [16]. The effect of light-activated PTN against C. tropicalis and other clinically relevant fungal pathogens, such as Candida albicans, Candida glabrata, and Candida auris, has been described using a light-emitting diode (LED) irradiation system (λ = 428 nm). Although yeast growth inhibition was achieved at a lower concentration of PTN (0.156 μg/mL vs. 0.98 μg/mL), a significantly higher irradiation dose was required (30 J/cm2 vs. 0.59 J/cm2) [31]. Therefore, the lower irradiation dose employed was compensated by using a higher concentration of PS, without exhibiting cytotoxic effects on normal cells. Furthermore, the irradiation system employed in our study is widely used in phototherapy for the treatment of hyperbilirubinemia in humans (https://www.lighting.philips.es/prof/lamparas-y-tubos-convencionales/lamparas-especiales/diversas-aplicaciones-uv/PHOTHER_SU/category, accessed on 7 April 2025).
Similarly, Ma et al. investigated the in vitro PDI mediated by aloe-emodin on azole-sensitive and -resistant C. albicans planktonic yeasts [32]. After incubation with 10 μM aloe-emodin and irradiation with 96 J/cm2 of light, approximately 6.5 log10 reductions in the survival of azole-sensitive and -resistant C. albicans were achieved. Their findings further support the potential of anthraquinone derivatives as effective PSs against fungal pathogens, as they observed a significant reduction in yeast after light activation. In their study, a higher irradiation dose (96 J/cm2) was required to achieve substantial antifungal effects, in contrast to the lower doses employed in our work.
Our study also evaluated the PDI of an AQ on a Candida spp., but this was PTN on C. tropicalis biofilms. In the dark, PTN showed no antifungal effect at any of the concentrations tested (up to 5.9 μg/mL ≈ 20.7 μM). However, under actinic irradiation, the antibiofilm effect increased significantly, resulting in a 99.9% decrease in viability. Our results reveal that twice the concentration of PTN was required to produce the photodynamic effect in biofilms compared to planktonic growth. This is because biofilms are more resistant than their planktonic counterparts, as they are complex three-dimensional structures; however, they appear to favor the interaction of AQ, beginning the aggregation at a high concentration (pMICx4), as observed in Figure 3. This behavior has already been observed for other AQs (rubiadin and rubiadin-1-methyl ether) in previous studies [21]. Other natural PSs that align with the blue-light emission spectrum are curcumin and riboflavin. In this sense, Quishida et al. [33] investigated the PDI of curcumin and LED light against C. albicans, C. glabrata, and Streptococcus mutans biofilm. The findings revealed that aPDT significantly decreased biofilm viability, metabolic activity, and biomass. However, the photoantibiofilm effect required high concentrations of curcumin (80, 100, and 120 μM). Alshehri et al. [34] examined the effectiveness of PDI using 0.1% riboflavin on C. albicans biofilms. Blue LED light was utilized to activate riboflavin, and fungal cell viability was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Treatment with riboflavin and LED resulted in the lowest survival rate of C. albicans, with viability below 50%.
Furthermore, other AQs such as emodin, alizarin, alizarin red, chrysazin, quinalizarin, purpurin, and 1-hydroxyanthra-9, 10-quinone have been shown to inhibit biofilm formation of C. albicans. The efficacy of emodin against C. albicans biofilm of strains isolated from hospitalized patients was achieved in the range of 200–400 μg/mL [35]. Alizarin and chrysazin reduced the metabolic activity of C. albicans biofilms by >98% at 10 μg/mL and by 66% at 2 μg/mL, respectively [36]. Moreover, inhibition of C. albicans biofilm formation by anthraquinones-related compounds, namely pyrocatechol, alizarin red, quinalizarin, emodin, 1-hydroxyanthra-9,10-quinone, purpurin, chrysazin, and alizarin has shown to be dose-dependent [35,37]. In addition, the antifungal activity of alizarin has been largely attributed to the presence of aromatic hydroxyl groups (-OH) in its AQ core [36]. This suggests that variations in the position of the -OH groups significantly influence the antibiofilm properties. Among the AQs tested, those with a -OH group at position-1(adjacent to the carbonyl group) exhibited the highest activity in all assays. Notably, purpurin, chrysazin, and alizarin, which share an -OH group at the C1 position, demonstrated strong inhibitory effects against Candida albicans biofilms even at low concentrations (2 μg/mL) [36]. Therefore, the antibiofilm activity of PTN against C. tropicalis may be influenced by the presence of the -OH group at position-1 in the AQ structure.
Besides the AQs, hypericin (a dianthrone) and porphyrins have emerged as promising PSs with high selectivity for fungal pathogens. Hypericin-mediated aPDT demonstrated significant antifungal activity, achieving substantial reductions in Candida biofilm and planktonic cell viability. Furthermore, hypericin activated by yellow or orange light effectively affected fluconazole-resistant Candida strains with minimal cytotoxicity to host tissues [38,39].
Porphyrins are PSs with high selectivity to pathogens. Thus, the photoinactivation of different Candida spp. by two cationic porphyrins derived from tetra-chloride salts, meso-tetra(4-N-methylpyridyl) porphyrin and meso-tetra(3-N-methylpyridyl)porphyrin derivatives (4-H2TMeP+ and 3-H2TMeP+), and anionic porphyrin tetra-sodium salt, meso-tetra(4-sulfonatophenyl)porphyrin (4-H2TPSP−) was investigated by Amorin et al. [40]. For the irradiation process, a white-light LED and light dosage of 10.9 J/cm2 was used. Cationic porphyrins can photoinactivate different Candida spp. in both planktonic and biofilm forms. C. tropicalis showed 35.8% interference when treated with 4-H2TMeP+, and 51.67% with 3-H2TMeP+ at 75uM for both porphyrins [40]. In addition, the tetracationic metalloporphyrin Zn(II) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin (ZnTnHex-2-PyP4+) was assayed against biofilms of C. albicans strains (ATCC 10231 and ATCC 90028) using a blue light-emitting diode. The PDI (4.3 J/cm2) at 0.8 μM showed about 89% decrease in the cell viability as assessed by the MTT assay [41].
Therefore, PTN stands out as an effective PS against Candida tropicalis, displaying strong antifungal and antibiofilm activity upon light activation, whereas remaining non-toxic in the dark. As an AQ-based compound, it benefits from a well-defined photoreactive core, structural stability, and required -OH positioning, which enhances its photodynamic efficacy. Its potent effect, even at low irradiation doses, makes it a promising alternative to other natural PSs that require higher concentrations or light doses for comparable activity.
The photoinactivation mechanism of C. tropicalis biofilms by PTN was investigated to identify the photoprocesses occurring in PTN-PDI.
Tiron inhibits the photoinactivation C. tropicalis biofilm by PTN at bioactive concentration. Although Tiron is a quencher of O2•−, it can react with hydroxyl radicals (HO) [42]. Since HO production occurs after the O2•− generation and Tiron was added before the irradiation period, it can be inferred that Tiron acted as a scavenger of O2•−. Thus, the Type I photosensitization mechanism would be mainly involved in PTN-mediated PDI in the biofilm. Furthermore, our previous work showed that PTN can produce O2•−, being an efficient Type I photosensitizer [16]. On the other hand, sodium azide only has a limited protective effect on C. tropicalis biofilm, despite PTN being an efficient 1O2 producer [16]. This type of behavior has also been reported for other AQs, such as rubiadin and its methylated derivative. For both AQs, it was shown that the main photosensitizing mechanism involved in the photoinduced antibiofilm activity is the O2•− formation through suppression of AQ excited states by electron transfer, whereas the role of 1O2 seems to be less significant [25].
Oxidative stress is a complex process that occurs because of two main factors: an overproduction of ROS, specifically by O2•− levels (Type I mechanism), given the short lifetime of singlet oxygen (3 μs) [43], and a reduction in oxidative defenses. Thus, this excessive ROS cannot be compensated by the enzymatic and non-enzymatic antioxidant systems of the biofilm, which make them insufficient to remove free radicals, resulting in damage to macromolecules (DNA, protein, lipids) and cellular components (cell membrane) [44,45].
When studying the biofilm response to this oxidative burst, NO generation should also be assessed as a response to O2•− levels, since this occurs more rapidly than the enzymatic response of SOD, thus promoting biofilm photoinactivation [46]. Elevated levels of NO (µM concentration) can cause cytotoxicity by inducing oxidative and nitrosative stress, leading to DNA damage, enzyme modification, cellular dysfunction, inflammation, mitochondrial impairment, and apoptosis. NO can inhibit key mitochondrial enzymes, such as aconitase, and disrupt respiratory chain complexes. It also reacts with O2•−, at a faster rate than with oxygen, to form the toxic peroxynitrite (OONO), which generates harmful radicals (HO and NO). It may react with H2O2 to produce 1O2, further intensifying damage [47,48].
Similar oxidative and nitrosative imbalances have been reported with other AQs, such as rubiadin and its 1-methyl ether derivative, isolated from Heterophyllaea pustulata. These compounds also induce significant photoreductions in biofilm formation of C. tropicalis, likely through similar mechanisms involving the overproduction of ROS and RNI [24].
In planktonic cells, oxidative stress induced by ROS overproduction has been extensively studied. Fiala et al. (2024) [31], showed that PTN targets the cell membrane and induces cell death via ROS-mediated lipid peroxidation after light irradiation on Candida planktonic yeast. Aloe-emodin has also been reported to induce photodynamic damage to the cell envelope of C. albicans planktonic form through ROS generation [32].
All this background suggests that the oxidative burst, resulting from ROS and RNI, is a common feature in the photoantimicrobial action of AQs, as our results also show.
The study of natural PSs contributes to the development of aPDT, which has proven to be selective, fast acting and has not developed resistance to date. This selectivity is achieved through strict spatial control of irradiation on the affected area (infection), thus uniting the three agents responsible for the photodynamic effect (PS, light, and 3O2). The PSs used in aPDT have not been shown to stimulate resistance mechanisms in microorganisms due to their multidimensional action, which generates a generalized oxidative imbalance that does not differentiate between resistant and non-resistant microorganisms. This photooxidation even includes the destruction of virulence factors, which are generally organic molecules susceptible to oxidation. Moreover, the PSs do not necessarily need to enter the cell to exert its action. Consequently, the pathogen cannot develop resistance through increased detoxification metabolism or export of the drug [49].

5. Conclusions

In conclusion, this study demonstrates that the photoinactivation of Candida tropicalis biofilms using PTN as the photosensitizer is primarily driven by O2•− (Type I mechanism), with 1O2 (Type II mechanism) playing a secondary role. However, the photodymamic effect is dependent on the concentration of PTN, since at higher concentration PTN self-aggregation effects play a role in the prompt deactivation of the excited states of the AQ. The results also show an imbalance in NO levels, which likely contributes to the cellular stress response and enhances the effectiveness of the treatment. The dominant role of O2•− in biofilm inactivation highlights its significance in the photodynamic mechanism of PTN. These findings suggest that PTN ability to disrupt fungal biofilms is linked to complex oxidative and nitrosative stress pathways, making PTN a promising candidate for antifungal PDT and potential clinical applications.

Author Contributions

Conceptualization and methodology, S.C.N.-M. and J.M.; software, J.M., M.L.M., B.C.R., T.I.G., F.M. and J.M.N.M.; formal analysis, J.M., B.C.R., C.D.B., F.M. and S.C.N.-M.; statistical analysis, F.M. and B.S.K.; writing—original draft preparation, J.M., C.D.B. and S.C.N.-M.; supervision, J.M., C.D.B., B.S.K. and S.C.N.-M.; resources, supervision, project administration, and funding acquisition, J.M., C.D.B. and S.C.N.-M. All authors have read and agreed to the published version of the manuscript.

Funding

S.C.N.-M. thanks SECyT (Consolidar, tipo 2, s/res. N° 411/18 y 155/22), and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET-PIP 2021–2023, s/res. 1639/2021). J.M. thanks the Fondo para la Investigación Científica y Tecnológica (FONCyT-PICT 2018 N° 4576, s/res. ANPCyT n° 401/19). C.D.B. thanks the CONICET, projects PUE-2018-035 and PIP-2020-101043CO, and FONCyT, Project PICT-2019-02052 of Argentina for financial support. The APC was not funded.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Acknowledgments

T.I.G., J.M.N.M. and B.C.R. are doctoral fellows at CONICET. F.M. and M.L.M. are post-doctoral fellows at CONICET. J.M., B.S.K., C.D.B. and S.C.N.-M. are members of the Research Career of CONICET. ChatGPT provided assistance in proofreading the English wording.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ΦΔQuantum yield of singlet oxygen
+CPositive control
1O2Singlet oxygen
3O2Molecular oxygen
AmB Amphotericin B
aPDIAntimicrobial photodynamic inactivation
aPDT Antimicrobial photodynamic therapy
AQ/sAnthraquinone/s
ATMAntimicrobial
CFUColony-forming units
CLSI Clinical and Laboratory Standards Institute
EtOHEthanol
FeSO4Ferrous sulfate
FRAP Ferrous Reduction Antioxidant Potency assay
H2O2Hydrogen peroxide
HOHydroxyl radical
MICMinimal inhibitory concentration
MOPSMorpholine propane sulfonic acid
NaN3Sodium azide
NaNO2Sodium nitrate
NaOHSodium hydroxide
NBTNitro-blue tetrazolium
NCPFNational Collection of Pathogenic Fungi
NONitric oxide
O2•−Superoxide radical anion
ODOptical density
PBSPhosphate buffered saline
pMICPhotoactive minimal inhibitory concentration
PSPhotosensitizer
PTNParietin
RNIReactive nitrogen intermediates
ROSReactive oxygen species
RPMIRoswell Park Memorial Institute 1640
SDASabouraud dextrose agar
SDBSabouraud dextrose broth
SODSuperoxide dismutase
MFCMinimum fungicidal concentration
MTT3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
-OHHydroxyl groups
DNA Deoxyribonucleic acid
OONOPeroxynitrite

References

  1. Ahmed, S.K.; Hussein, S.; Qurbani, K.; Ibrahim, R.H.; Fareeq, A.; Mahmood, K.A.; Mohamed, M.G. Antimicrobial Resistance: Impacts, Challenges, and Future Prospects. J. Med. Surg. Public Health 2024, 2, 100081. [Google Scholar] [CrossRef]
  2. Riera, F.O.; Caeiro, J.P.; Angiolini, S.C.; Vigezzi, C.; Rodriguez, E.; Icely, P.A.; Sotomayor, C.E. Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America. Antibiotics 2022, 11, 877. [Google Scholar] [CrossRef]
  3. Pappas, P.G.; Lionakis, M.S.; Arendrup, M.C.; Ostrosky-Zeichner, L.; Kullberg, B.J. Invasive candidiasis. Nat. Rev. Dis. Primers 2018, 4, 18026. [Google Scholar] [CrossRef]
  4. Aroso, R.T.; Schaberle, F.A.; Arnaut, L.G.; Pereira, M.M. Photodynamic Disinfection and Its Role in Controlling Infectious Diseases. Photochem. Photobiol. Sci. 2021, 20, 1497–1545. [Google Scholar] [CrossRef]
  5. Klausen, M.; Ucuncu, M.; Bradley, M. Design of Photosensitizing Agents for Targeted Antimicrobial Photodynamic Therapy. Molecules 2020, 25, 5239. [Google Scholar] [CrossRef]
  6. Aware, C.B.; Patil, D.N.; Suryawanshi, S.S.; Mali, P.R.; Rane, M.R.; Gurav, R.G.; Jadhav, J.P. Natural Bioactive Products as Promising Therapeutics: A Review of Natural Product-Based Drug Development. S. Afr. J. Bot. 2022, 151, 512–528. [Google Scholar] [CrossRef]
  7. Ranković, B.; Kosanić, M. Lichens as a Potential Source of Bioactive Secondary Metabolites. In Lichen Secondary Metabolites: Bioactive Properties and Pharmaceutical Potential; Springer International Publishing: Cham, Switzerland, 2019; pp. 1–29. [Google Scholar]
  8. Thakur, M.; Chander, H. Potential of lichens: A Review of Bioactive Compounds with Biological Activities. Biol. Forum Int. J. 2021, 13, 39–47. [Google Scholar]
  9. Poulsen-Silva, E.; Otero, M.C.; Diaz-Cornejo, S.; Atala, C.; Fuentes, J.A.; Gordillo-Fuenzalida, F. Secondary Metabolites of Lichens: The Untapped Biomedical and Pharmaceutical Potential of Antimicrobial Molecules. Fungal Biol. Rev. 2025, 51, 100410. [Google Scholar] [CrossRef]
  10. Kocovic, A.; Jeremic, J.; Bradic, J.; Sovrlic, M.; Tomovic, J.; Vasiljevic, P.; Andjic, M.; Draginic, N.; Grujovic, M.; Mladenovic, K.; et al. Phytochemical Analysis, Antioxidant, Antimicrobial, and Cytotoxic Activity of Different Extracts of Xanthoparmelia Stenophylla Lichen from Stara Planina, Serbia. Plants 2022, 11, 1624. [Google Scholar] [CrossRef]
  11. Kello, M.; Goga, M.; Kotorova, K.; Sebova, D.; Frenak, R.; Tkacikova, L.; Mojzis, J. Screening Evaluation of Antiproliferative, Antimicrobial and Antioxidant Activity of Lichen Extracts and Secondary Metabolites In Vitro. Plants 2023, 12, 611. [Google Scholar] [CrossRef]
  12. Aoussar, N.; Laasri, F.E.; Bourhia, M.; Manoljovic, N.; Mhand, R.A.; Rhallabi, N.; Ullah, R.; Shahat, A.A.; Noman, O.M.; Nasr, F.A.; et al. Phytochemical Analysis, Cytotoxic, Antioxidant, and Antibacterial Activities of Lichens. Evid. Based Complement. Alternat. Med. 2020, 2020, 8104538. [Google Scholar] [CrossRef]
  13. Christina Pires Gonçalves, L. Photophysical Properties and Therapeutic Use of Natural Photosensitizers. J. Photochem. Photobiol. 2021, 7, 100052. [Google Scholar] [CrossRef]
  14. Polat, E.; Kang, K. Natural Photosensitizers in Antimicrobial Photodynamic Therapy. Biomedicines 2021, 9, 584. [Google Scholar] [CrossRef] [PubMed]
  15. Fernández-Marín, B.; Artetxe, U.; Becerril, J.M.; Martínez-Abaigar, J.; Núñez-Olivera, E.; García-Plazaola, J.I. Can Parietin Transfer Energy Radiatively to Photosynthetic Pigments? Molecules 2018, 23, 1741. [Google Scholar] [CrossRef]
  16. Comini, L.R.; Morán Vieyra, F.E.; Mignone, R.A.; Páez, P.L.; Laura Mugas, M.; Konigheim, B.S.; Cabrera, J.L.; Núñez Montoya, S.C.; Borsarelli, C.D. Parietin: An Efficient Photo-Screening Pigment in Vivo with Good Photosensitizing and Photodynamic Antibacterial Effects in Vitro. Photochem. Photobiol. Sci. 2017, 16, 201–210. [Google Scholar] [CrossRef]
  17. Hurtado Bredda, F.J.; Nin Vaeza, N.; Rubbo Amonini, H. Estrés oxidativo y nitrosativo en la sepsis. Med. Intensive 2005, 29, 159–165. [Google Scholar] [CrossRef]
  18. Baltazar, L.M.; Ray, A.; Santos, D.A.; Cisalpino, P.S.; Friedman, A.J.; Nosanchuk, J.D. Antimicrobial Photodynamic Therapy: An Effective Alternative Approach to Control Fungal Infections. Front. Microbiol. 2015, 6, 202. [Google Scholar] [CrossRef]
  19. Ong, K.S.; Mawang, C.I.; Daniel-Jambun, D.; Lim, Y.Y.; Lee, S.M. Current Anti-Biofilm Strategies and Potential of Antioxidants in Biofilm Control. Expert Rev. Anti Infect. Ther. 2018, 16, 855–864. [Google Scholar] [CrossRef]
  20. M27-A2; Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard—Second Edition. NCCLS: Wayne, PA, USA, 2002.
  21. Mugas, M.L.; Calvo, G.; Marioni, J.; Céspedes, M.; Martinez, F.; Sáenz, D.; Di Venosa, G.; Cabrera, J.L.; Montoya, S.N.; Casas, A. Photodynamic Therapy of Tumour Cells Mediated by the Natural Anthraquinone Parietin and Blue Light. J. Photochem. Photobiol. B 2021, 214, 112089. [Google Scholar] [CrossRef]
  22. Marioni, J.; Arce, J.E.; Cabrera, J.L.; Paraje, M.G.; Núñez Montoya, S.C. Reduction of Candida tropicalis Biofilm by Photoactivation of a Heterophyllaea pustulata Extract. Pharm. Biol. 2016, 54, 2791–2801. [Google Scholar] [CrossRef]
  23. M27-A3; Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard—Third Edition. CLSI: Wayne, PA, USA, 2008.
  24. Marioni, J.; Da Silva, M.A.; Cabrera, J.L.; Montoya, S.C.N.; Paraje, M.G. The Anthraquinones Rubiadin and Its 1-Methyl Ether Isolated from Heterophyllaea Pustulata Reduces Candida Tropicalis Biofilms Formation. Phytomedicine 2016, 23, 1321–1328. [Google Scholar] [CrossRef] [PubMed]
  25. Marioni, J.; Bresolí-Obach, R.; Agut, M.; Comini, L.R.; Cabrera, J.L.; Paraje, M.G.; Nonell, S.; Montoya, S.C.N. On the Mechanism of Candida Tropicalis Biofilm Reduction by the Combined Action of Naturally-Occurring Anthraquinones and Blue Light. PLoS ONE 2017, 12, e0181517. [Google Scholar] [CrossRef]
  26. Mattila, H.; Khorobrykh, S.; Havurinne, V.; Tyystjärvi, E. Reactive Oxygen Species: Reactions and Detection from Photosynthetic Tissues. J. Photochem. Photobiol. B 2015, 152, 176–214. [Google Scholar] [CrossRef]
  27. Tsikas, D. Analysis of Nitrite and Nitrate in Biological Fluids by Assays Based on the Griess Reaction: Appraisal of the Griess Reaction in the l-Arginine/Nitric Oxide Area of Research. J. Chromatogr. B 2007, 851, 51–70. [Google Scholar] [CrossRef] [PubMed]
  28. Beauchamp, C.; Fridovich, I. Superoxide Dismutase: Improved Assays and an Assay Applicable to Acrylamide Gels. Anal. Biochem. 1971, 44, 276–287. [Google Scholar] [CrossRef]
  29. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef]
  30. Youf, R.; Müller, M.; Balasini, A.; Thétiot, F.; Müller, M.; Hascoët, A.; Jonas, U.; Schönherr, H.; Lemercier, G.; Montier, T.; et al. Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies. Pharmaceutics 2021, 13, 1995. [Google Scholar] [CrossRef]
  31. Fiala, J.; Roach, T.; Holzinger, A.; Husiev, Y.; Delueg, L.; Hammerle, F.; Armengol, E.S.; Schöbel, H.; Bonnet, S.; Laffleur, F.; et al. The Light-Activated Effect of Natural Anthraquinone Parietin against Candida Auris and Other Fungal Priority Pathogens. Planta Med. 2024, 90, 588–594. [Google Scholar] [CrossRef]
  32. Ma, W.; Liu, C.; Li, J.; Hao, M.; Ji, Y.; Zeng, X. The Effects of Aloe Emodin-Mediated Antimicrobial Photodynamic Therapy on Drug-Sensitive and Resistant Candida Albicans. Photochem. Photobiol. Sci. 2020, 19, 485–494. [Google Scholar] [CrossRef]
  33. Quishida, C.C.C.; De Oliveira Mima, E.G.; Jorge, J.H.; Vergani, C.E.; Bagnato, V.S.; Pavarina, A.C. Photodynamic Inactivation of a Multispecies Biofilm Using Curcumin and LED Light. Lasers Med. Sci. 2016, 31, 997–1009. [Google Scholar] [CrossRef]
  34. Alshehri, A.H. Mechanical and Antimicrobial Effects of Riboflavin-Mediated Photosensitization of in Vitro C. Albicans Formed on Polymethyl Methacrylate Resin. Photodiagnosis Photodyn. Ther. 2021, 36, 102488. [Google Scholar] [CrossRef]
  35. Janeczko, M.; Masłyk, M.; Kubiński, K.; Golczyk, H. Emodin, a Natural Inhibitor of Protein Kinase CK2, Suppresses Growth, Hyphal Development, and Biofilm Formation of Candida albicans. Yeast 2017, 34, 253–265. [Google Scholar] [CrossRef]
  36. Manoharan, R.K.; Lee, J.-H.; Kim, Y.-G.; Lee, J. Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Candida Albicans. Front. Cell. Infect. Microbiol. 2017, 7, 447. [Google Scholar] [CrossRef]
  37. Tsang, P.W.-K.; Bandara, H.M.H.N.; Fong, W.-P. Purpurin Suppresses Candida Albicans Biofilm Formation and Hyphal Development. PLoS ONE 2012, 7, e50866. [Google Scholar] [CrossRef]
  38. Galinari, C.B.; Biachi, T.D.P.; Gonçalves, R.S.; Cesar, G.B.; Bergmann, E.V.; Malacarne, L.C.; Kioshima Cotica, É.S.; Bonfim-Mendonça, P.D.S.; Svidzinski, T.I.E. Photoactivity of Hypericin: From Natural Product to Antifungal Application. Crit. Rev. Microbiol. 2023, 49, 38–56. [Google Scholar] [CrossRef]
  39. Łopaciński, M.; Fiegler-Rudol, J.; Niemczyk, W.; Skaba, D.; Wiench, R. Riboflavin- and Hypericin-Mediated Antimicrobial Photodynamic Therapy as Alternative Treatments for Oral Candidiasis: A Systematic Review. Pharmaceutics 2024, 17, 33. [Google Scholar] [CrossRef]
  40. Amorim, C.F.; Iglesias, B.A.; Pinheiro, T.R.; Lacerda, L.E.; Sokolonski, A.R.; Pedreira, B.O.; Moreira, K.S.; Burgo, T.A.L.; Meyer, R.; Azevedo, V.; et al. Photodynamic Inactivation of Different Candida Species and Inhibition of Biofilm Formation Induced by Water-Soluble Porphyrins. Photodiagnosis Photodyn. Ther. 2023, 42, 103343. [Google Scholar] [CrossRef]
  41. Souza, S.O.; Raposo, B.L.; Sarmento-Neto, J.F.; Rebouças, J.S.; Macêdo, D.P.C.; Figueiredo, R.C.B.Q.; Santos, B.S.; Freitas, A.Z.; Cabral Filho, P.E.; Ribeiro, M.S.; et al. Photoinactivation of Yeast and Biofilm Communities of Candida Albicans Mediated by ZnTnHex-2-PyP4+ Porphyrin. J. Fungi 2022, 8, 556. [Google Scholar] [CrossRef]
  42. Bors, W. Pulse-Radiolytic Investigations of Catechols and Catecholamines II. Reactions of Tiron with Oxygen Radical Species. Biochim. Biophys. Acta BBA Gen. Subj. 1979, 582, 537–542. [Google Scholar] [CrossRef] [PubMed]
  43. Snyder, J.W.; Skovsen, E.; Lambert, J.D.C.; Poulsen, L.; Ogilby, P.R. Optical Detection of Singlet Oxygen from Single Cells. Phys. Chem. Chem. Phys. 2006, 8, 4280. [Google Scholar] [CrossRef] [PubMed]
  44. Vatansever, F.; De Melo, W.C.M.A.; Avci, P.; Vecchio, D.; Sadasivam, M.; Gupta, A.; Chandran, R.; Karimi, M.; Parizotto, N.A.; Yin, R.; et al. Antimicrobial Strategies Centered around Reactive Oxygen Species—Bactericidal Antibiotics, Photodynamic Therapy, and Beyond. FEMS Microbiol. Rev. 2013, 37, 955–989. [Google Scholar] [CrossRef] [PubMed]
  45. Elian, C.; Méallet, R.; Versace, D. Photoactive Dye–Loaded Polymer Materials: A New Cutting Edge for Antibacterial Photodynamic Therapy. Adv. Funct. Mater. 2024, 34, 2407228. [Google Scholar] [CrossRef]
  46. Wink, D.A.; Mitchell, J.B. Chemical Biology of Nitric Oxide: Insights into Regulatory, Cytotoxic, and Cytoprotective Mechanisms of Nitric Oxide. Free Radic. Biol. Med. 1998, 25, 434–456. [Google Scholar] [CrossRef] [PubMed]
  47. Fraix, A.; Sortino, S. Combination of PDT Photosensitizers with NO Photodononors. Photochem. Photobiol. Sci. 2018, 17, 1709–1727. [Google Scholar] [CrossRef]
  48. Zhao, Z.; Li, H.; Tao, X.; Xie, Y.; Yang, L.; Mao, Z.; Xia, W. Light-Triggered Nitric Oxide Release by a Photosensitizer to Combat Bacterial Biofilm Infections. Chem. Eur. J. 2021, 27, 5453–5460. [Google Scholar] [CrossRef]
  49. Tavares, A.; Carvalho, C.M.B.; Faustino, M.A.; Neves, M.G.P.M.S.; Tomé, J.P.C.; Tomé, A.C.; Cavaleiro, J.A.S.; Cunha, Â.; Gomes, N.C.M.; Alves, E.; et al. Antimicrobial Photodynamic Therapy: Study of Bacterial Recovery Viability and Potential Development of Resistance after Treatment. Mar. Drugs 2010, 8, 91–105. [Google Scholar] [CrossRef]
Figure 1. Chemical structure of parietin (1,8-dihydroxy-3-methoxy-6-methyl-9,10-anthraquinone, PTN).
Figure 1. Chemical structure of parietin (1,8-dihydroxy-3-methoxy-6-methyl-9,10-anthraquinone, PTN).
Pharmaceutics 17 00548 g001
Figure 2. MIC determination of parietin (PTN) under darkness and irradiation conditions. Optical density values obtained for planktonic cells at 530 nm, previously treated with different concentrations of PTN. * p < 0.05 with respect to C. tropicalis. # p < 0.05 darkness vs. irradiation.
Figure 2. MIC determination of parietin (PTN) under darkness and irradiation conditions. Optical density values obtained for planktonic cells at 530 nm, previously treated with different concentrations of PTN. * p < 0.05 with respect to C. tropicalis. # p < 0.05 darkness vs. irradiation.
Pharmaceutics 17 00548 g002
Figure 3. Photoinactivation studies and photodynamic mechanism of C. tropicalis biofilms with parietin at five concentrations, using pMIC (0.98 μg/mL ≈ 3.45 μM) as reference and actinic irradiation (L+) vs. darkness (L−). * p < 0.05 with respect to C. tropicalis. # p < 0.05 darkness vs. irradiation.
Figure 3. Photoinactivation studies and photodynamic mechanism of C. tropicalis biofilms with parietin at five concentrations, using pMIC (0.98 μg/mL ≈ 3.45 μM) as reference and actinic irradiation (L+) vs. darkness (L−). * p < 0.05 with respect to C. tropicalis. # p < 0.05 darkness vs. irradiation.
Pharmaceutics 17 00548 g003
Figure 4. Reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI) production on C. tropicalis biofilm treated with parietin and irradiation, using pMIC (0.98 μg/mL ≈ 3.45 μM) as reference. Data were obtained by the colony-forming unit (CFU) count test, corresponding to viable biofilm. * p < 0.05 with respect to C. tropicalis.
Figure 4. Reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI) production on C. tropicalis biofilm treated with parietin and irradiation, using pMIC (0.98 μg/mL ≈ 3.45 μM) as reference. Data were obtained by the colony-forming unit (CFU) count test, corresponding to viable biofilm. * p < 0.05 with respect to C. tropicalis.
Pharmaceutics 17 00548 g004
Figure 5. Activation of superoxide dismutase enzyme (SOD) and total antioxidant capacity (FRAP) in C. tropicalis biofilm treated with parietin and irradiation, using pMIC (0.98 μg/mL ≈ 3.45 μM) as reference. Data were obtained by the colony-forming unit (CFU) count test, corresponding to viable biofilm. * p < 0.05 compared to C. tropicalis.
Figure 5. Activation of superoxide dismutase enzyme (SOD) and total antioxidant capacity (FRAP) in C. tropicalis biofilm treated with parietin and irradiation, using pMIC (0.98 μg/mL ≈ 3.45 μM) as reference. Data were obtained by the colony-forming unit (CFU) count test, corresponding to viable biofilm. * p < 0.05 compared to C. tropicalis.
Pharmaceutics 17 00548 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Marioni, J.; Romero, B.C.; Mugas, M.L.; Martinez, F.; Gómez, T.I.; Morales, J.M.N.; Konigheim, B.S.; Borsarelli, C.D.; Nuñez-Montoya, S.C. The Natural Anthraquinone Parietin Inactivates Candida tropicalis Biofilm by Photodynamic Mechanisms. Pharmaceutics 2025, 17, 548. https://doi.org/10.3390/pharmaceutics17050548

AMA Style

Marioni J, Romero BC, Mugas ML, Martinez F, Gómez TI, Morales JMN, Konigheim BS, Borsarelli CD, Nuñez-Montoya SC. The Natural Anthraquinone Parietin Inactivates Candida tropicalis Biofilm by Photodynamic Mechanisms. Pharmaceutics. 2025; 17(5):548. https://doi.org/10.3390/pharmaceutics17050548

Chicago/Turabian Style

Marioni, Juliana, Bianca C. Romero, Ma. Laura Mugas, Florencia Martinez, Tomas I. Gómez, Jesús M. N. Morales, Brenda S. Konigheim, Claudio D. Borsarelli, and Susana C. Nuñez-Montoya. 2025. "The Natural Anthraquinone Parietin Inactivates Candida tropicalis Biofilm by Photodynamic Mechanisms" Pharmaceutics 17, no. 5: 548. https://doi.org/10.3390/pharmaceutics17050548

APA Style

Marioni, J., Romero, B. C., Mugas, M. L., Martinez, F., Gómez, T. I., Morales, J. M. N., Konigheim, B. S., Borsarelli, C. D., & Nuñez-Montoya, S. C. (2025). The Natural Anthraquinone Parietin Inactivates Candida tropicalis Biofilm by Photodynamic Mechanisms. Pharmaceutics, 17(5), 548. https://doi.org/10.3390/pharmaceutics17050548

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop